This indicates Th2 cells play an immunosuppressive role independent of mutation load in ccRCC.[4] In summary, our results have demonstrated that Th2 CD4+ T cells could play an immunosuppressive role in regulating the TME of ccRCC. This evidence concerns the gene CD4 and nonpapillary renal cell carcinoma.